Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001213900-22-015852
Filing Date
2022-03-29
Accepted
2022-03-29 16:31:06
Documents
67
Period of Report
2021-12-31

Document Format Files

Seq Description Document Type Size
1 ANNUAL REPORT f10k2021_cormedixinc.htm   iXBRL 10-K 1537104
2 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM f10k2021ex23-1_cormedixinc.htm EX-23.1 1965
3 CERTIFICATION f10k2021ex31-1_cormedixinc.htm EX-31.1 11265
4 CERTIFICATION f10k2021ex31-2_cormedixinc.htm EX-31.2 11456
5 CERTIFICATION f10k2021ex32-1_cormedixinc.htm EX-32.1 4590
6 GRAPHIC image_001.jpg GRAPHIC 75783
  Complete submission text file 0001213900-22-015852.txt   6690606

Data Files

Seq Description Document Type Size
7 XBRL SCHEMA FILE crmd-20211231.xsd EX-101.SCH 66042
8 XBRL CALCULATION FILE crmd-20211231_cal.xml EX-101.CAL 37486
9 XBRL DEFINITION FILE crmd-20211231_def.xml EX-101.DEF 287612
10 XBRL LABEL FILE crmd-20211231_lab.xml EX-101.LAB 599790
11 XBRL PRESENTATION FILE crmd-20211231_pre.xml EX-101.PRE 302564
61 EXTRACTED XBRL INSTANCE DOCUMENT f10k2021_cormedixinc_htm.xml XML 687676
Mailing Address 300 CONNELL DRIVE SUITE 4200 BERKELEY HEIGHTS NJ 07922
Business Address 300 CONNELL DRIVE SUITE 4200 BERKELEY HEIGHTS NJ 07922 908-517-9500
CorMedix Inc. (Filer) CIK: 0001410098 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-34673 | Film No.: 22781313
SIC: 2834 Pharmaceutical Preparations